Expert Review of Anticancer Therapy

Published by: Taylor & Francis Group  

People

  1. Lee
    Lee
  2. Morrow
    Morrow
  3. Motzer
    Motzer
  4. Epstein
    Epstein
  5. Fornier
    Fornier
  6. Ilson
    Ilson
  7. Leitao
    Leitao
  8. Rosenberg
    Rosenberg
  9. Shah
    Shah
  10. Sonoda
    Sonoda

Groups

  1. Department of Medicine (33)
  2. Solid Tumor Oncology Division (26)
  3. Surgery (13)
  4. Genitourinary Oncology Service (10)
  5. Survivorship Research (8)
  6. Breast Medicine Service (6)
  7. Gastrointestinal Oncology Service (6)
  8. Gynecology Disease Management Team (6)
  9. Hematologic Malignancies, Division of (6)
  10. Radiation Oncology, Department of (5)
Search Within
Formats
  1. Journal Article (55)
  2. Review (11)
  3. Editorial (2)
Groups
  1. Department of Medicine (33)
  2. Solid Tumor Oncology Division (26)
  3. Surgery (13)
  4. Genitourinary Oncology Service (10)
  5. Survivorship Research (8)
  6. Breast Medicine Service (6)

More Groups

People
  1. Patrick Morris (4)
  2. Monica Morrow (3)
  3. Nancy Lee (3)
  4. Robert Motzer (3)
  5. Andrew Epstein (2)
  6. David Ilson (2)

More People

Years
  1. 2024 (1)
  2. 2023 (2)
  3. 2022 (5)
  4. 2021 (1)
  5. 2020 (3)
  6. 2019 (3)

More Years

Publishers
  1. Taylor & Francis Group (68)

Results (68)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • How to manage prolonged immune effector cell-associated hematotoxicity (ICAHT) related to BCMA-directed myeloma therapy
    Editorial

    Davis, J. A.; McGann, M.; Marini, J.; Hashmi, H.
    Expert Review of Anticancer Therapy (2024)

    Fulltext@MSK | Save
  • A 24-month updated analysis of the comparative effectiveness of ZUMA-5 (axi-cel) vs. SCHOLAR-5 external control in relapsed/refractory follicular lymphoma
    Journal Article

    Palomba, M. L.; Ghione, P.; Patel, A. R.; Nahas, M.; Beygi, S.; Hatswell, A. J.; Kanters, S.; Limbrick-Oldfield, E. H.; Wade, S. W.; Ray, M. D.; more...
    Expert Review of Anticancer Therapy (2023)

    Fulltext@MSK | Save
  • Characterization and management of adverse events observed with mobocertinib (TAK-788) treatment for EGFR exon 20 insertion–positive non–small cell lung cancer
    Review

    Yang, J. C. H.; Zhou, C.; Jänne, P. A.; Ramalingam, S. S.; Kim, T. M.; Riely, G. J.; Spira, A. I.; Piotrowska, Z.; Mekhail, T.; Garcia Campelo, M. R.; more...
    Expert Review of Anticancer Therapy (2023)

    Fulltext@MSK | Save
  • Lenvatinib plus pembrolizumab combination therapy for adult patients with advanced renal cell carcinoma
    Review

    Ged, Y.; Lee, C. H.
    Expert Review of Anticancer Therapy (2022)

    Fulltext@MSK | Save
  • Evaluating new treatments for anaplastic thyroid cancer
    Review

    Coca-Pelaz, A.; Rodrigo, J. P.; Lopez, F.; Shah, J. P.; Silver, C. E.; Al Ghuzlan, A.; Menke-van der Houven van Oordt, C.; Smallridge, R. C.; Shaha, A. R.; Angelos, P.; more...
    Expert Review of Anticancer Therapy (2022)

    Fulltext@MSK | Save
  • Addressing the problem of overtreatment in breast cancer
    Review

    Pak, L. M.; Morrow, M.
    Expert Review of Anticancer Therapy (2022)

    Fulltext@MSK | Save
  • Lenvatinib dose, efficacy, and safety in the treatment of multiple malignancies
    Review

    Motzer, R. J.; Taylor, M. H.; Evans, T. R. J.; Okusaka, T.; Glen, H.; Lubiniecki, G. M.; Dutcus, C.; Smith, A. D.; Okpara, C. E.; Hussein, Z.; more...
    Expert Review of Anticancer Therapy (2022)

    Fulltext@MSK | Save
  • Myeloid-derived suppressor cells: A grey eminence in the AML tumor microenvironment?
    Editorial

    Bewersdorf, J. P.; Zeidan, A. M.
    Expert Review of Anticancer Therapy (2022)

    Fulltext@MSK | Save
  • The evolution of cyclin dependent kinase inhibitors in the treatment of cancer
    Journal Article

    Jhaveri, K.; Burris, H. A. 3rd; Yap, T. A.; Hamilton, E.; Rugo, H. S.; Goldman, J. W.; Dann, S.; Liu, F.; Wong, G. Y.; Krupka, H.; more...
    Expert Review of Anticancer Therapy (2021)

    Fulltext@MSK | Save
  • The current clinical approach to newly diagnosed uterine cancer
    Review

    Filippova, O. T.; Leitao, M. M.
    Expert Review of Anticancer Therapy (2020)

    Fulltext@MSK | Save

    • Expert Review of Anticancer Therapy – authorized name for:

    Name ISSN / ISBN Publisher
    Expert Review of Anticancer Therapy 1473-7140 Taylor & Francis Group
    Expert Review of Anticancer Therapy 1473-7140 Taylor & Francis Group
    Expert Review of Anticancer Therapy 1473-7140 Future Drugs Ltd
    Expert Review of Anticancer Therapy 1473-7140 Taylor & Francis Group
    Expert Review of Anticancer Therapy 14737140 Informa Uk Limited, Trading As Taylor & Francis Group
    Expert Review of Anticancer Therapy 14737140 2018, © 2018 Informa Uk Limited, Trading As Taylor & Francis Group
    Expert Review of Anticancer Therapy 1473-7140 Informa Healthcare
    Expert Review of Anticancer Therapy 14737140 2019, © 2019 Informa Uk Limited, Trading As Taylor & Francis Group
    Expert Review of Anticancer Therapy 14737140 Expert Reviews Ltd
    Expert Review of Anticancer Therapy 17448328 Informa Healthcare
    Expert Review of Anticancer Therapy 14737140 Future Drugs Ltd
    Expert Review of Anticancer Therapy 14737140 Informa Healthcare
    Expert Review of Anticancer Therapy 1473-7140 Future Drugs Ltd
    Expert Review of Anticancer Therapy 1473-7140 Taylor & Francis Group
    Expert Review of Anticancer Therapy 1473-7140 Expert Reviews
    Expert Review of Anticancer Therapy 1473-7140 Unknown
    Expert Review of Anticancer Therapy 14737140 Unknown
    Expert Review of Anticancer Therapy 14737140 Expert Reviews
    Expert Review of Anticancer Therapy 1473-7140 Taylor & Francis Group
    Expert Review of Anticancer Therapy 1473-7140 Informa Healthcare
    Expert Review of Anticancer Therapy 1473-7140 Taylor & Francis
    Expert Review of Anticancer Therapy 14737140 Informa Healthcare
    Expert Review of Anticancer Therapy 1473-7140 Taylor & Francis Group
    Expert Review of Anticancer Therapy 1473-7140 Taylor & Francis Group
    Expert Review of Anticancer Therapy 14737140 Informa Healthcare